Tonix Pharmaceuticals Holding (TNXP) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $47.7 million.
- Tonix Pharmaceuticals Holding's Other Gross PP&E Adjustments rose 4.40% to $47.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $177.2 million, marking a year-over-year decrease of 36.34%. This contributed to the annual value of $36.6 million for FY2024, which is 58.53% down from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its Other Gross PP&E Adjustments stood at $47.7 million for Q3 2025, which was up 1.62% from $47.0 million recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's 5-year Other Gross PP&E Adjustments high stood at $98.6 million for Q1 2024, and its period low was $36.6 million during Q4 2024.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was $47.7 million (2025), whereas its average is $68.0 million.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Other Gross PP&E Adjustments slumped by 58.53% in 2024, and later grew by 4.40% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Other Gross PP&E Adjustments (Quarterly) stood at $88.3 million in 2023, then slumped by 58.53% to $36.6 million in 2024, then increased by 4.40% to $47.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at $47.7 million for Q3 2025, versus $47.0 million for Q2 2025 and $45.9 million for Q1 2025.